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Background: The ethical discourse about HIV testing has undergone a profound transformation in recent years.
The greater availability of antiretroviral therapy (ART) has led to a global scaling up of HIV testing and counseling as
a gateway to prevention, treatment and care. In response, critics raised important ethical questions, including: How
do different testing policies and practices undermine or strengthen informed consent and medical confidentiality?
How well do different modalities of testing provide benefits that outweigh risks of harm? To what degree do
current testing policies and programs provide equitable access to HIV services? And finally, what lessons have been
learned from the field about how to improve the delivery of HIV services to achieve public health objectives and
protections for human rights? This article reviews the empirical evidence that has emerged to answer these
questions, from four sub-Saharan African countries, namely: Burkina Faso, Kenya, Malawi and Uganda.
Discussion: Expanding access to treatment and prevention in these four countries has made the biomedical
benefits of HIV testing increasingly clear. But serious challenges remain with regard to protecting human rights,
informed consent and ensuring linkages to care. Policy makers and practitioners are grappling with difficult ethical
issues, including how to protect confidentiality, how to strengthen linkages to care, and how to provide equitable
access to services, especially for most at risk populations, including men who have sex with men.
Summary: The most salient policy questions about HIV testing in these countries no longer address whether to
scale up routine PITC (and other strategies), but how. Instead, individuals, health care providers and policy makers
are struggling with a host of difficult ethical questions about how to protect rights, maximize benefits, and mitigate
risks in the face of resource scarcity.
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The ethical discourse about HIV testing has undergone a
profound transformation in recent years. For the decade and
a half after HIV tests became available in 1985, ethical con-
cerns centered on the right not to be tested, since an HIV
diagnosis provided few medical benefits and posed serious
risks of stigma and discrimination [1]. Discussions among
ethicists, human rights advocates and policy makers
focused on the 3-Cs: counseling, voluntary informed con-
sent and confidentiality [2]. However, the greater availabil-
ity of antiretroviral therapy (ART), and growing evidence* Correspondence: cm39@aub.edu.lb
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distribution, and reproduction in any mediumthat ART can prevent transmission of HIV have strength-
ened public health arguments for scaling up access to test-
ing as a gateway to prevention, treatment and care [3,4].
Thus, the policy discourse shifted away from the right not
to be tested to the right to know. In 2006, United Nations
(UN) Member States committed themselves to universal
access to treatment, which required a dramatic scale up in
testing [5]. By 2007, WHO (World Health Organization)
and UNAIDS (The Joint United Nations Programme on
HIV/AIDS) guidelines recommended that all patients in
settings with generalized epidemics be offered HIV testing
routinely during clinical encounters – also known as
provider-initiated counseling and testing (PITC) – and
proposed streamlined counseling and consent procedures
[2]. By 2010, 32 of 38 countries with generalized HIVtral Ltd. This is an Open Access article distributed under the terms of the
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, provided the original work is properly cited.
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providers to initiate testing and counseling in all clinical
encounters [6]. Countries have invested in a range of other
testing strategies as well, including stand-alone sites, mo-
bile, home-based, index, and self-testing, as well as one-off
and annual campaigns [6].
This expansion of testing prompted debates within the
bioethics and human rights literature [7]. Critics asked
whether routine PITC would threaten fundamental rights
to voluntary, informed consent and confidentiality, whether
confidentiality would be protected in overstretched health
care facilities, whether clinical settings would provide ad-
equate post-test counseling, support and linkages to treat-
ment, and whether benefits would outweigh the risks of
adverse consequences such as stigma, rejection and spousal
abuse [8-15]. There have also been questions about how to
balance HIV-positive individuals' right to medical confiden-
tiality with the need to prevent transmission to others and
to diagnose partners living with HIV [16,17]. In addition,
there have been concerns about how to ensure equitable
access to testing and treatment for those who face barriers
to testing and care in sub-Saharan Africa, particularly most
at risk groups [18,19].
Based on the limited but growing body of empirical evi-
dence that has begun to shed light on these questions, this
paper reviews what is known from the public health,
human rights and policy literature about the ethical dimen-
sions of expanding HIV testing in sub-Saharan Africa. To
illustrate the evolution of testing policies and their imple-
mentation on the ground, we focus on four sub-Saharan
African countries, namely: Burkina Faso, Kenya, Malawi
and Uganda, selected to complement field research of the
MATCH (Multi-country African Testing and Counseling
for HIV) study, which investigated clients' and providers'
experiences of HIV testing across different testing moda-
lities in these countries.
Methods
The literature searches for this review were conducted
among a wide range of sources within the public health,
social science literature, ethics and human rights litera-
ture. Search engines and databases such as PubMed,
POPLINE and Google Scholar were scanned for the
following key terms: HIV testing and counseling, PITC,
routine testing, HIV disclosure, confidentiality, consent,
partner notification, mandatory testing, HIV policies and
legislation, criminalization of transmission, human rights,
as well for sources specific to each of the four MATCH
study countries. We included any paper that presented
data about testing programs and policies in the 4 countries
or that discussed different approaches to testing and the
implementation of testing programs. Many sources had
been identified in the course of preparing earlier papers
on HIV disclosure, consent, and the human rightsimplications of different modes of delivering HIV testing
and counseling. In addition, this review drew on docu-
ments, reports and guidelines published by United
Nations (UN) agencies such as the Joint United Nations
Programme on HIV/AIDS (UNAIDS), the World Health
Organization (WHO), and non-governmental organiza-
tions (NGOs).
By reviewing evidence from four countries, we direct
attention to sources that provided insight into “Prime;
ethics on the ground” rather than to more theoretical
discussions that have been the focus of much of the
international literature. To this end, this paper is struc-
tured in three parts: a) a description of how testing
policies and practices have changed in the four coun-
tries; b) a review of evidence about what ethical implica-
tions these changes have for the health, rights and
wellbeing of individuals, families and communities; and
finally c) a synthesis of key ethical challenges and re-
search gaps that should be addressed. This paper focuses
on those issues most relevant for adults living with HIV,
as some issues particular to children or adolescents are
beyond the scope of this review.
Review
Expansion of HIV testing and counseling in Burkina Faso,
Kenya, Malawi, and Uganda
Burkina Faso, Kenya, Malawi, and Uganda exemplify dif-
ferent epidemiological profiles, cultural contexts, policies
and health service responses [6]. All four have generalized
epidemics, but as noted in Table 1, the estimated HIV
prevalence among adults aged 15-49 ranges from 1.2% in
Burkina Faso, to 6.3% in Kenya, 6.5% in Uganda, and 11%
in Malawi [20].
Before HIV treatment became more widely available,
most people who tested in these countries (and globally)
did so in the context of client-initiated 'voluntary testing
and counseling' (VCT). Utilization of testing was low, both
as a proportion of those estimated to be living with HIV
and relative to the proportion who said they would like to
know their status, as documented in Kenya, Malawi and
Uganda [18,21-23]. Certain population groups faced par-
ticular barriers to testing. For example, women were less
likely than men to use VCT in parts of Kenya and Uganda
[24], and less likely than men to receive services in the
course of testing campaigns in Burkina Faso [25]. Barriers
to testing for both women and men included fear of
stigma and lack of confidentiality, long distances to VCT
sites, lack of perceived benefits, and delays in receiving
results (before rapid testing) [21].
As HIV treatment became more widely available, all
four countries expanded access to testing, each following
its own unique trajectory. Three of the four countries
received PEPFAR funding for HIV/AIDS prevention,
treatment and care. Between 2004 and 2009, Kenya and
Table 1 Selected HIV indicators for Burkina Faso, Kenya, Malawi and Uganda, 2009 and 2010
Estimated prevalence of HIV
among adults aged 15-49, 2009
Estimated percentage
of adults aged 15+
who received HIV
testing and counseling
in the past 12 months, 2010
Estimated percentage of
pregnant women
tested for HIV, 2010
Estimated ART
coverage (among all age groups)
based on 2010
WHO guidelines, 2010
Country % [Range] % % % [Range]
Burkina Faso 1.2 [1.0-1.5] 7.3 54 49 [44-55]
Kenya 6.3 [5.8-6.5] 29.1 83 61 [56-66]
Malawi 11.0 [10.0-12.1] 25.8 66 na [49-57]
Uganda 6.5 [5.9-6.9] 18.1 63 47 [43-51]
Source: [6,20].
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USD 1.9 million and USD 1.2 million respectively, while
Malawi received about USD 0.16 million [26]. Malawi
used decentralization and task shifting to lower level
health personnel to scale up testing in the context of re-
source constraints [27,28]. Burkina Faso expanded HIV
services through a unique network of community-based
organizations, in partnership with government and inter-
national organizations [29,30]; they also carried out large
national testing campaigns [31]. Kenya set ambitious an-
nual targets and launched large door-to-door home-
based testing programs, outreach and mobile services
for most-at risk populations, as well as integrated rural
campaigns that combined HIV testing, malaria and diar-
rhea prevention [32-34]. Uganda also used a diversified
portfolio of approaches, including campaigns, VCT, PITC
and large home-based testing efforts in rural areas [35,36].
Much expansion of testing in these countries occurred
through increased PITC within clinical services such as
antenatal care (ANC), tuberculosis care, and hospital in-
patient settings. In fact, national guidelines recommend-
ing PITC in clinical settings were issued in Kenya [37],Figure 1 Estimated number of health facilities providing HIV testing a
available for Kenya 2007. 2. Source for 2007-2009 data: [40]; source for 2010Malawi [38], and Uganda [39], even before WHO and
UNAIDS published their 2007 guidelines [2]. In Burkina
Faso, PITC was expanded more recently (around 2007),
though it was available earlier at some health facilities.
As illustrated by Figure 1, statistics show remarkable
increases in the number of testing sites in all four coun-
tries in recent years [6,40]. In Kenya, for example, the
number of testing sites increased from 3 in 2000 to more
than 4,000 in 2009 [6,41]. As a result, by 2009, the pro-
portion of health facilities offering routine PITC had
reached an estimated 73% of facilities [41]. Similarly, in
Uganda, they increased from 3 in 2002 to more than
1,200 by 2009 [5].
As a result of this expansion, the number and percent-
age of individuals ever tested has also increased over the
past decade, as illustrated by findings from population-
based surveys in all four countries, as presented in Figure 2
[42-50]. As noted in Table 1, by 2010, the WHO estimates
that the percentage of individuals aged 15 and older who
had received an HIV test and results in the past 12 months
had risen to 7% in Burkina Faso, 29% in Kenya, 26% in
Malawi, and 18% in Uganda [6,51].nd counseling, by country and year. Notes: 1. No estimate is
data: [6].
Figure 2 Percentage of adults aged 15-49 who ever had an HIV test and received results, DHS and AIS surveys 2000-2011. Sources:
Demographic (DHS) and AIDS Indicator Survey (AIS) final reports [43-50]. Note however that the Burkina Faso 2003 DHS and Uganda 2000-1 DHS
final reports did not include these indicators in a comparable format, so those figures were drawn from the comparative analysis of DHS data by
Mishra and colleagues [42].
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Does routine PITC undermine voluntary informed consent?
One important question about expanding routine PITC
was whether it would undermine voluntary informed con-
sent. Critics suggested that clients, especially women in
antenatal care, might perceive routine PITC as mandatory;
that power differentials between patients and providers
would make it difficult for patients to refuse testing; and
that streamlined pre-test procedures might weaken the
quality of counseling [12].
While PITC was designed to increase testing in all
health facilities, including those providing inpatient ser-
vices, tuberculosis care, and male circumcision, most
available evidence on consent comes from studies of
antenatal care facilities. Predictions that routine testing
in clinical settings would increase utilization of testing
have been borne out. When the Mbale Regional Hospital
in Eastern Uganda shifted from a client-initiated, opt in
approach to a routine PITC approach in 2006, rates of
testing increased from 20% to 87.6% of attendees [52].
Similarly dramatic increases in testing uptake within
ANC were documented in Burkina Faso [30], Kenya
[53], Malawi [27] and other settings in Uganda [52,54].
By 2010, the estimated proportion of pregnant women
tested nationally had risen to 54% in Burkina Faso, 66%
in Malawi, 83% in Kenya and 63% in Uganda [6]; and in
some facilities with routine PITC, acceptance rates
exceeded 95% [27,53,55].
Earlier studies cited high uptake of testing through PITC
as evidence of “acceptability” [56,57], though it was
acknowledged that returning for results (required before
rapid tests were available) was much lower, suggesting a
degree of ambivalence about testing. More recently, while
some researchers, including from Malawi, concluded thatthey found “no evidence of coercion” [27], high acceptance
rates raise the possibility that routine PITC is difficult for
pregnant women to refuse. Indeed, several studies from
Burkina Faso, Kenya, Malawi, and Uganda have found that
while many women report feeling no pressure to test,
many others believe that HIV testing in ANC is compul-
sory, feel they cannot refuse the advice of a physician, and
are not clearly told that testing is optional; they feel pres-
sured by staff who heavily emphasize their responsibility
and the benefits for their baby [53,58-61].
A number of studies have concluded that the quality
and comprehensiveness of counseling varies widely:
patients in antenatal care and other services are sometimes
given inadequate information about their right to decline,
the consent process and the benefits and rationale for HIV
testing, and they are not always given time to ask ques-
tions or make decisions, as documented in Burkina Faso
[62], Kenya [63] and the MATCH study countries [64].
It may however be problematic to assume that women
who previously did not seek out or who declined testing
before routine PITC were exercising informed, autono-
mous choice. Decisions about testing are complex, and
studies have documented many reasons why pregnant
women do not test or receive results (whether in client-
initiated VCT or when offered a routine test by a pro-
vider), including low risk awareness, fear of stigma, lack of
perceived benefits, time and cost burdens. Before testing
within ANC became routine, an important barrier to test-
ing in all four countries was that many women felt they
could not test without their husband's or family's
permission, whom they often believed would oppose test-
ing; this was reported in Burkina Faso [62], Kenya [24],
Malawi [22], and Uganda [65-69]. Similarly, in Malawi,
men told researchers that HIV testing by a wife without
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Evidence suggests that the introduction of routine testing
within antenatal care can make it easier for women who
want to test to do so with less fear of partner or family
opposition, as reported in studies from Burkina Faso [71],
Kenya [53,68,69], Malawi [70] and Uganda [65,72]. In
explaining the dramatic increase in acceptance of HIV
testing following the introduction of routine PITC in
Lilongwe, Malawi, researchers wrote: “the new ANC
attendees were less fearful of accepting HIV testing be-
cause routine testing was perceived by their partners and
families as standard of care given to all pregnant women
in the clinic” [52]. Similarly, a study in Uganda found that
routine testing made it easier for women to test without
their husband's permission, because testing was seen as
being done for the baby's health [72].
This evidence suggests two possible changes: a) rou-
tine testing policies may encourage women to test with-
out asking for partner or family permission; and b) the
policy shift may increase partners' and families' support
for HIV testing. Routinizing testing may thus contribute
to shifting the decision from the moral realm—testing be-
cause of reprehensible behavior—to the health realm—
testing as a standard part of prenatal care and for the
baby's health. It is likely that similar shifts have occurred
in other health facilities, and that where testing is pro-
vider-initiated, it loses some of its exceptional nature and
becomes a routine medical procedure.Does PITC lead to benefits? Access to prevention, support
and treatment
The ethical and public health rationale for routine testing
depends heavily on the potential for diagnosis to lead to
prevention and treatment [4]. Thus, one key question is
whether those who test positive are able to access counsel-
ing, support, treatment and care following diagnosis.
Many have voiced concern that PITC policies may be ac-
companied by reduced levels of counseling and high levels
of loss to follow up, both of which weaken the rationale
for scaled up testing [11,12,73].
More than a decade ago, research had indicated that
HIV testing and counseling could contribute to reducing
risk behaviors among those who tested both negative and
positive [74]. One concern has been that lower levels of
counseling in PITC programs would undermine this pre-
ventive potential. In fact, some research, including a study
from three districts in Kenya, Tanzania, and Zambia found
that counseling provided in the context of PITC was “li-
mited” and concluded that the services missed important
opportunities for prevention [63]. This is a particular con-
cern both for those who are HIV-negative, and for those
who test positive for HIV, but do not qualify for treatment
under current guidelines.Another key question is how well these programs ensure
linkages to care. In recent years, governments in all four
countries have placed a high priority on expanding access
to treatment [41,51,75,76]. As a result, the numbers and
percentages of eligible individuals receiving treatment
have increased accordingly, as illustrated by Figure 3
[6,40]. Nonetheless, barriers to treatment pose continuing
challenges in all four countries. A systematic review of evi-
dence from sub-Saharan African countries (including
Kenya, Malawi and Uganda) found substantial loss to fol-
low up at every stage between HIV diagnosis, pre-ART
care, and ART initiation [77], as have studies from Burkina
Faso [78,79], Kenya [80-83], Malawi [19,84-86], and
Uganda [87-89].
Measuring loss to follow-up can be challenging, given
high mobility of patients in the four countries. In addition,
rates of attrition after HIV diagnosis are often difficult to
compare across studies, due to different definitions of lin-
kages to care (e.g. whether provision of cotrimoxazole or
registration at a clinic is sufficient, or whether ART is a
necessary element in the package). Moreover, the situation
in the field may be changing rapidly, and studies from a
few years ago may not reflect current conditions. Typical,
however, is a study from Kenya among women diagnosed
with HIV in a PMTCT (Prevention of mother to child
transmission) program, which found that after exiting the
program, half had changed residence; 74% of those located
reported going to the HIV referral program, but 33% sub-
sequently discontinued care, mostly because they did not
qualify for treatment [82]. Another study among adults
already eligible for ART in Kenya and Malawi found high
levels of attrition both before and after starting ART, ei-
ther through loss to follow-up, death, or stopping treat-
ment, including 23% of patients in Malawi and 15% in
Kenya during the pre-ART phase, and another 26% in
Malawi and 23% in Kenya after beginning ART; overall
program attrition was 43% [80].
A host of factors contribute to attrition after diagnosis,
including policies that render many recently diagnosed
HIV-positive patients ineligible for treatment, the chal-
lenge of following patients who do not yet qualify for
ART, problems with pre-ART referral systems [77,90], and
generally weak health systems. In some settings, ART
stock-outs, inadequate pre-antiretroviral care and a lack of
staff confidentiality also appear to pose barriers to care
[91]. In a study from Kenya, women who did not access
care after being diagnosed in PMTCT cited concerns
about confidentiality and poor quality services [82]. In
addition, attending pre-ART care before treatment eligibi-
lity may involve high costs for HIV-positive individuals,
both in terms of money and time, often with few perceived
benefits [77]. In Burkina Faso, pre- ART patients who wish
to become eligible for treatment often must pay for
laboratory monitoring, transport and accommodation,
Figure 3 WHO estimates of ART coverage among all age groups 2005-2010, by country and year. Notes: This indicator is defined as the
percentage of adults and children with advanced HIV infection currently receiving ART in accordance with nationally approved treatment
protocols (or WHO/UNAIDS standards) among the estimated number of adults and children with advanced HIV infection. No point estimate is
available for Malawi in 2010. The estimated range is 49-57%, as noted in Table 1. Source for 2007-2009 data: [40]; source for 2010 data: [6].
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transport was an important reason why treatment eligible
respondents said they had not started ART [93]. In
Uganda, 39% of patients in one study had dropped out of
treatment after enrollment by year three, and while some
had sought treatment elsewhere, those who did not cited
lack of transportation and work/child care responsibilities
as primary reasons [94].
Social and cultural factors also play a role in loss to fol-
low-up. In Malawi, HIV-positive women cited a broad
range of reasons for dropping out of PMTCT or pre-ART
services, including fears of negative reactions from partners,
friends and community, unequal gender relations, and lack
of support from husbands, as well as fatalism about HIV
[84,95,96]. In another study from Malawi, HIV-positive
men reported postponing treatment because of masculine
ideals of strength, because they feared losing the respect of
friends or partners, or because of concerns that entering
treatment would reduce their chances of (re)marriage [96].
In some cases, women in Kenya dropped out of PMTCT
because they believed their children had been healed
through faith or traditional medicine [97]. Another study
from Kenya found that women who had not accessed care
were less likely to believe that ART was effective or to have
disclosed their HIV status to their partners [82]. In fact,
most studies found that fear of stigma and lack of disclos-
ure to family and friends were important barriers to HIV
care following diagnosis. Lack of disclosure also poses a
barrier to preventive behaviors, such as breastfeeding with
early weaning or formula feeding, as documented in studies
from Burkina Faso [98] and Malawi [85].
Health programs from the region have implemented
many strategies to improve linkages to care andretention in pre-ART services and to better define what
should be provided to those HIV-positive but not eligible
for ART. Some provide point of care CD4 testing and
prophylaxis for opportunistic infections [77]; others, such
AMPATH in western Kenya, have found that loss to fol-
low up has declined over time, possibly because they have
increased the number of parent and satellite clinics, pro-
vided more comprehensive care (e.g. giving food supple-
ments) and enhanced community outreach efforts [99].
Governments have also tried various policies and strat-
egies to improve access to care. Burkina Faso recently
eliminated user fees for ART [92]. Malawi introduced sim-
plified initiation criteria for pregnant women [90], decen-
tralized HIV service delivery and shifted responsibility for
ART initiations to non-physician clinicians—a strategy
that was linked to a doubling of ART enrollment in some
districts [28]. These efforts are promising, and increased
numbers of individuals receiving treatment represents
progress. On the other hand, some have expressed con-
cern that reduced international funding for HIV treatment
programs globally may undermine these efforts, through
increased treatment stock-outs, restrictions in enrolment
of new patients, and the re-emergence of ART user-fees in
settings such as Burkina Faso [92].
Does PITC lead to adverse consequences?
A major ethical concern in debates about expanded test-
ing is whether adverse consequences that sometimes fol-
low an HIV diagnosis will outweigh benefits, especially
in light of barriers to care cited above. A large body of
evidence from sub-Saharan Africa indicates that fears of
negative reactions by partners, families and communities
pose important barriers to HIV testing, prevention and
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consequence of testing during antenatal care is that
women are often first to know their HIV status and
hence, they may be accused of having brought HIV into
a couple, as documented in an analysis of qualitative
data from the MATCH study [101]. A recent study in
antenatal clinics in Kenya found that while fewer than
4% of women declined the routine offer of HIV testing,
substantial proportions of all 1,525 women interviewed
believed they would experience serious adverse conse-
quences if they tested positive including 28.3% who
thought they would be rejected by their family, 25.6%
who believed they would be physically abused by their
partner, and 32.1% who thought their relationship would
end [102].
While fears of negative consequences have been repeat-
edly documented, the extent of actual adverse events fol-
lowing HIV diagnosis has been more difficult to assess. A
2004 review of studies from developing countries (includ-
ing two studies from Burkina Faso and one from Kenya)
found that negative reactions to disclosure, such as blame,
abandonment and violence, were relatively infrequent,
ranging from 3-15% [103]. These low rates must be con-
sidered in light of several other factors, however. First,
women selectively disclose their HIV-positive status, and
they may not disclose to partners whom they expect
would respond badly [17,104]. Second, HIV-positive
women in serodiscordant relationships appear to be at
increased risk [105]. Third, in some settings, adverse
events can be more frequent. In one community in
Malawi, abandonment following HIV disclosure by preg-
nant women was so high that the community called the
PMTCT service “the divorce program” [106]. On the other
hand, researchers note that because most studies are
retrospective, it is not always possible to determine a
causal link between the adverse events and HIV disclos-
ure, as domestic abuse may have preceded disclosure
[107]. Moreover, in Malawi, researchers suggested that di-
vorce was not always the least desirable outcome, particu-
larly for women who were in a bad relationship, and it
could sometimes facilitate women's access to treatment,
when natal families provided better care during their ill-
ness than unsupportive husbands [96]. In addition, living
with undiagnosed HIV (the alternative to testing) carries
its own risks, including eventual illness and possibly death,
and may simply postpone negative reactions.
How to balance disclosure, confidentiality, and partner
notification
Lack of disclosure to partners – both by women and
men – poses serious ethical challenges, particularly given
that considerable proportions of those living with HIV are
members of serodiscordant couples, including large ma-
jorities in Burkina Faso, Kenya, and Malawi [104,108] andnearly half of those diagnosed with HIV in Uganda [109].
A recent review [17] found that disclosure rates in the re-
gion varied widely, with lower rates typically reported for
partner disclosure compared to disclosure to other family
members. While women and men may fear negative con-
sequences of disclosure, secrecy carries its own burdens,
including isolation, lack of support in the face of a poten-
tially life threatening disease, and concerns about trans-
mitting the infection to partners or children [98]. Health
care providers in these countries often struggle to balance
a duty to notify partners at risk with a competing ethical
obligation to protect the medical confidentiality, safety
and wellbeing of those living with HIV [9]. In one study in
Kenya, maternity care providers found it inconceivable
that a husband would not be informed if his wife tested
positive for HIV [110]. When confronted with guidelines
that appeared to bar breaches of confidentiality, counse-
lors in Malawi sometimes bent the rules if they believed
that family members or partners should know a client's
HIV status [111,112]. In Uganda, researchers found that
HIV counselors “struggled to decide how to act when
members of discordant couples refused to reveal their
HIV status, leaving partners or children at risk”, and they
described wanting more guidance in this area [61].
Policy makers are also grappling with the dilemma of
confidentiality and its limits. In Burkina Faso, a 2008 law
mandates disclosure to sex partners and criminalizes
transmission under certain circumstances [113]. In
Uganda, proposed legislation would mirror provisions of
Burkina Faso's law. There is little systematic evidence
about the extent to which such laws are enforced, but
some argue that women may be more vulnerable to
prosecution for non-disclosure or criminal transmission
than men in sub-Saharan Africa because they are more
likely both to be HIV-positive and to know their status
due to routine testing in ANC [114]. There is consensus
within the international public health and human rights
community that criminalizing nondisclosure undermines
human rights and serves no useful public health benefit
[115,116]. There is less consensus about the ethics of
partner notification, however. In the face of nondisclo-
sure to sexual partners, some argue that partner notifica-
tion, even without patients' consent, may be “the lesser
of the two evils” [16]. Guidelines issued by the UN High
Commissioner for Human Rights and UNAIDS, and pol-
icies in Kenya suggest that health workers may disclose
patients' HIV status without their consent if a risk of
HIV transmission exists, as long as they meet certain
conditions, including concealing the identity of the
patient (if possible) and providing follow-up support
[117,118]. In this region, however, such conditions are
difficult to fulfill and little is known about how to pro-
tect HIV-positive clients who might be placed at risk
through involuntary third party disclosure [119].
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have been assessed through a recent randomized trial in
Malawi, and researchers concluded that it was “feasible,
acceptable, and effective”, as well as virtually harmless
[120]. However, some important ethical questions are left
unanswered; for example, most index patients were mar-
ried to their only partner, and it isn't clear to what extent
the identity of the index patient could be concealed [121].
It is also noteworthy that at least some patients who were
eligible for the study declined to participate because they
did not want their HIV status disclosed.
Concerns about equity
Another theme in the international ethical discourse
about HIV testing is the concept of equity. Are those
who need HIV services able to access them? And con-
versely, do some groups—particularly those at higher
risk—face disproportionate barriers to testing, treatment
and support [18]? Concerns about equitable access to
testing have focused on a number of population groups,
including men, adolescents, rural populations who lack
access to health services, prisoners in custodial settings,
and most-at-risk populations such as men who have sex
with men, sex workers, and injecting drug users.
Ensuring male access to HIV testing
One striking consequence of the scale-up of testing
within ANC is that in many sub-Saharan African set-
tings, a higher proportion of women than men know
their HIV-positive status and are receiving treatment; for
example, according to WHO statistics, an estimated 55%
of women in sub-Saharan Africa who needed antiretro-
viral therapy were receiving it, compared with 41% of
men [6]. Gender imbalances in access to testing or treat-
ment have also been documented in individual studies
from Burkina Faso [122,123], Kenya [99], Malawi [19],
and Uganda. Part of the numerical gender imbalance
reflects the fact that women comprise a higher propor-
tion of those living with HIV than men; however, in
many settings, men have lower utilization of health ser-
vices than women, and therefore, fewer opportunities to
test and receive HIV care early in the infection, and they
often delay testing and/or treatment until they become
symptomatic [18,96,124]. From an equity perspective,
there is also concern that testing pregnant women in
ANC without testing their male partners represents a
missed opportunity to diagnose or prevent transmission
of HIV in light of persistent rates of nondisclosure.
Many HIV programs have sought to reach men by try-
ing to increase testing among partners of antenatal care
patients and by promoting couples counseling and other
“family-centered” approaches. Programs in Malawi, Rwanda
and Zambia found that community mobilization and
outreach strategies increased the use of couplescounseling in ANC clinics [125-127], and some programs
in the four countries have reported success with a “facili-
tated disclosure approach” [128]. However, PMTCT pro-
grams in Africa still find it difficult to reach male partners
of women in ANC care [129], as noted in studies from
Burkina Faso [62], Kenya [130-132], Malawi [106], and
Uganda [59,133,134]. Couple counseling has also posed
challenges in terms of how couples are defined and how
health programs can maximize disclosure and support,
while minimizing the risk of adverse consequences, par-
ticularly for women at risk of intimate partner violence.
Concerns about equity: increasing access to HIV services for
most-at-risk populations
Despite official commitments from all four countries to
overcome disparities in testing, most-at-risk population
groups, including sex workers, injecting drug users, and
prisoners, but particularly men who have sex with men,
continue to face barriers to access. Regional reviews note
that HIV policies and programming in sub-Saharan Africa
historically focused almost exclusively on heterosexual
transmission, with a corresponding neglect of research,
surveillance, prevention, treatment and care for men who
have sex with men [135-139]. Smith and colleagues argue
that this neglect stems from a context of extreme political,
cultural and religious hostility towards such men in the
region, where male-to-male sex is illegal in 31 countries
(including in Kenya, Malawi and Uganda) and punishable
by the death penalty in four countries, a provision that is
not yet law in any of the MATCH countries, but is being
considered in Uganda [135,140]. This context of hostility
has serious negative consequences for access to HIV ser-
vices. For example, in Malawi the 2010 UNGASS report
suggested that men who had sex with men had less access
to testing services than female sex workers and that stigma
and barriers to care are rising due to recent arrests of men
who have sex with men [75]. Some efforts to reach men
who have sex with men are underway in Kenya, though
these are still on a limited scale and have yet to be repli-
cated in many parts of the region [136].
What are the ethical implications of other strategies for
improving access?
The role of campaigns
One commonly used approach to reaching underserved
populations in sub-Saharan Africa has been national or
local testing and counseling campaigns, including mass
media awareness and mobilization, as well as campaigns
that provide services directly, for example, through mo-
bile clinics and home-based testing. Campaigns have
been implemented in all four countries [141,142], but
they have been particularly important in Burkina Faso
where, a considerable proportion of all testing occurs
during annual campaigns [31]. In Kenya, an integrated,
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high rates of testing uptake [33,143], and a media cam-
paign to promote HIV testing and counseling between
2002 and 2005 was linked to a substantial increase in
testing uptake [144]. In Malawi a week-long campaign
aimed at mobilizing people to test has been carried out
annually for several years; “Testing Week” has been
linked to improvements in testing uptake and is cur-
rently being formally evaluated [75,145].
Campaigns have strengths and weaknesses. While it is
clear that they increase awareness of potential benefits
of testing, there has been little empirical investigation
into whether campaigns may pressure those who—for
whatever reason—do not wish to be tested. Some ex-
press concerns that those who test during campaigns are
not always able to access follow-up care and prevention,
as noted in Kenya [32]. On the other hand, evidence
suggests that campaigns can reach underserved groups.
For example, a campaign targeting sex workers in Kenya
tested over 6,000 women and clients during a five-day
“moonlight” campaign [41]. And in Burkina Faso, cam-
paigns have been used to target hard to reach groups
such as sex workers, men who have sex with men, and
young people aged 14-25 [31]. Home-based testing cam-
paigns were designed to address equity by overcoming
barriers to attending designated clinics such as distance,
cost of transport and concerns about confidentiality
[146]. While a 2010 Cochrane Collaborative Report con-
cluded that “the impact of home-based VCT on the up-
take of HIV testing is unclear in developing countries”
[147], considerable enthusiasm for this approach is evi-
dent. It is clear from available reports that home-based
testing can overcome certain socio-economic barriers to
access, particularly for those living in rural areas far
from a health facility [22,32,146]. A study from rural
Kenya found that a strategy of community meetings
and scheduled household contacts reached nearly
two-thirds of eligible adults aged 15-49 in the com-
munity, almost all of whom agreed to be tested
[148]. In Kenya and Uganda, home-based strategies
reached populations with low rates of prior testing
and with higher CD4 counts than those tested in
other settings [35,36,149-151]. Some have voiced
concerns, however, that when testing within the
household context, individuals may be pressured by
family members to agree to testing or to disclose
their results; there are also serious concerns about
how to link those who test positive to follow-up
care, especially in rural areas with limited access to
health facilities [32].
Other testing and counseling strategies
In addition to campaigns and home testing, there have
been a host of less well documented strategies forexpanding testing in the region, including workplace
testing initiatives [152], self-testing [153], and index pa-
tient testing initiatives similar to those described earlier
by Brown and colleagues [120]. Each of these strategies
has its own implications for consent, confidentiality and
linkages to care, and the evidence base on ethical and
human rights implications is still emerging.Discussion
This review highlights a number of findings about scaling
up HIV testing in Burkina Faso, Kenya, Malawi, and
Uganda. First, the scale, design, availability, and quality of
HIV services are changing rapidly in these settings. As a
result empirical evidence about HIV services may become
outdated within a short period of time, which is one im-
portant limitation of this review. Second, there is great
variety in the ways in which HIV testing and counseling
services are delivered – both among and within the coun-
tries profiled in this paper. There is also a diversity of
quality of care, outcomes for patients, provider practices,
and the extent to which patients access treatment and care
after being diagnosed with HIV. In other words, there is
no monolithic “resource poor setting”. A systematic ana-
lysis of how these differences affect key ethical questions
is beyond the scope of this paper, but it is an important
issue for researchers to address in the future.
Regarding the ethical dimensions of HIV testing, this re-
view suggests a number of findings. First, ethical concerns
voiced at the international level do not always correspond
to debates on the ground, as illustrated by the decision by
governments in Kenya, Malawi, and Uganda to implement
routine PITC even before WHO and UNAIDS issued their
2007 guidelines [2], despite international controversy over
this approach. The most salient policy questions about
HIV testing in these countries is no longer whether to
scale up routine PITC (and other strategies), but how. In-
stead, individuals, health care providers and policy makers
are struggling with a host of difficult ethical questions
about how to protect rights, maximize benefits, and miti-
gate risks in the face of resource scarcity.
The international ethical discourse about HIV testing
has focused on four main questions: how do different test-
ing policies and practices undermine or strengthen
informed consent and medical confidentiality? How well
do different modalities of testing provide benefits that out-
weigh risks of harm? To what degree do current testing
policies and programs provide equitable access to HIV ser-
vices? And finally, what lessons have been learned from
the field about how to improve the delivery of HIV ser-
vices to achieve public health objectives and protections
for human rights?
Concerns that routine PITC might undermine informed
consent have some merit, as illustrated by women in ANC
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women. On the other hand, routine PITC may have
strengthened women's ability to make autonomous deci-
sions about their own health in settings where, prior to
routine PITC, women believed that they did not have the
right to test without their husband's or family's consent. A
comparative analysis of consent in the four MATCH
countries has shown high levels of consent across modes
of testing (86%), with the level only slightly lower (83%)
among PMTCT testers [64]. Routine PITC has complex
implications for autonomous consent: while these policies
make it harder to say no for those women who wish to de-
cline or are ambivalent, they make it easier for those who
wish to know their status to say yes. This has been most
clearly demonstrated for women in antenatal care, but it
may apply to other groups and testing modalities as well.
For example, authors of a ten country study in southern
Africa concluded that large proportions of the population
want to know their status but “may not feel empowered to
get themselves tested” [18].
With regard to risks and benefits, some evidence sug-
gests that negative life events following HIV disclosure
are less common than once feared [107], and it is pos-
sible that stigma and discrimination may decline as ac-
cess to testing and treatment expands. Meanwhile,
expanding access to testing and treatment in these four
countries has made the biomedical benefits of HIV test-
ing increasingly clear for individuals, their children, and
their partners. WHO estimates suggest that the greater
availability of ART has helped reduce AIDS related mor-
tality globally, and within sub-Saharan Africa specifically,
where an estimated 30% fewer people died from AIDS-
related causes in 2010 than in 2004, following the dra-
matic expansion in access to ART in that region [6].
Moreover, evidence about the potential public health
benefits of testing and treatment is changing rapidly.
Until recently, researchers believed that expanding test-
ing could reduce HIV prevalence primarily by encour-
aging people to reduce high risk sexual behavior [4].
However, research published in 2011 found that early
treatment of those who tested positive reduced transmis-
sion to partners by 96%, suggesting that testing com-
bined with early treatment has enormous untapped
potential for prevention [154]. As the knowledge base
on treatment as prevention grows, policy makers will
have to address questions about the ethical and public
health rationale for eligibility requirements that delay
treatment until patients meet criteria based on CD4
counts [155]. At the same time, individuals who test
positive for HIV in these four countries often face ser-
ious barriers to care, and expanded testing will not pro-
vide full benefits for those living with HIV until health
systems can address the systemic, social and economic
challenges that undermine linkages to care [77].Conclusion
In sum, evidence from these countries suggests that the
expansion of testing and counseling services—including
routine PITC—can increase access to services and achieve
positive health outcomes. It also suggests a myriad of ways
in which HIV services need to address protections for
human rights. Policy makers and practitioners are still
grappling with important ethical issues. One is how to en-
sure equitable access to HIV testing and treatment for
rural populations, adolescents, men, and high risk groups
such as men who have sex with men. Another is how to
balance patients' right to confidentiality with the duty to
prevent transmission to partners and children at risk. The
difficult ethical issues related to involuntary disclosure and
partner notification have yet to be resolved in many of these
settings. A third issue is what health service approaches can
reduce the risk of negative consequences of disclosure, e.g.
through facilitated disclosure, couples counseling, integrat-
ing attention to violence against women, and broader
efforts to reduce HIV stigma. Finally, the legality, ethics, ad-
visability and practicality of third party disclosure continue
to fuel policy debates in these countries—without clear or
easy solutions.
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